JP Morgan Chase’s Nightstar Therapeutics NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-12,066
Closed -$306K – 6171
2019
Q1
$306K Sell
12,066
-7,840
-39% -$139K ﹤0.01% 4440
2018
Q4
$229K Buy
19,906
+9,443
+90% +$126K ﹤0.01% 4530
2018
Q3
$214K Buy
+10,463
New +$215K ﹤0.01% 4667

JP Morgan Chase's NITE Position: Q2 2019 in Review

JP Morgan Chase sold out of Nightstar Therapeutics (NITE) in Q2 2019, closing a stake of 12,066 shares — an estimated $306K sold.

JP Morgan Chase first reported a position in NITE in Q3 2018 and held it in 3 quarters. The position peaked at $306K in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • JP Morgan Chase reported no remaining Nightstar Therapeutics position as of Q2 2019 after selling out during the quarter.
  • JP Morgan Chase sold 12,066 Nightstar Therapeutics shares in Q2 2019, an estimated $306K.
  • JP Morgan Chase first reported a position in Nightstar Therapeutics in Q3 2018 and held it in 3 quarters.
  • JP Morgan Chase's Nightstar Therapeutics position peaked at $306K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics as of Q2 2019.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.